Osmetech to Run Qiagen Respiratory Test on MDx Platform | GenomeWeb
NEW YORK (GenomeWeb News) – Osmetech said today that it will adapt a Qiagen respiratory viral test for use on its eSensor XT-8 molecular diagnostics system.
 
Qiagen will supply Osmetech with its QIAplex-based reagents for the multiplex amplification of the most common viruses associated with respiratory infections. UK-based Osmetech said that it will develop an in vitro diagnostic test for use on its molecular diagnostics platform and submit the test for US Food and Drug Administration clearance.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.